Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy.
about
Evaluation and management of dyslipidemia in patients with HIV infection.HIV protease inhibitors and obesityHuman immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseaseImproved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemiaDiagnostic markers based on a computational model of lipoprotein metabolismA Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.Cardiometabolic disease in human immunodeficiency virus-infected children.Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy.
P2860
Q34743413-3DB52049-95D6-4F35-87E7-96B780E98D20Q34792983-BE535743-3167-49C2-8BFB-48BAA6C697E1Q35104006-63558910-5983-4D31-81EA-71EDDAAAD9D0Q35384143-AD8AE497-CF82-45EE-A2AF-D8693352C1EDQ35834874-4B6F24AE-396E-49BE-8535-FE7793616524Q35899038-DB383CF0-70B6-4BC1-B009-4DE151EBC1FDQ37016598-0266D26E-FAFE-4EBB-8183-E3FF2CB7DD90Q37086312-426E039A-F47E-4343-A0FE-9746C66501FAQ39670294-53EC8A68-50EF-487F-86BF-E4AFC0C74CCDQ40096020-894092AE-47C0-49E8-8762-8C9782D7F667Q40389936-E76EEFDF-D185-4097-A6CC-089F0C93FAD8Q44004417-DA9FEC07-0D52-4B19-843E-1B84E5AF6B06
P2860
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alterations of apolipoprotein ...... etroviral combination therapy.
@ast
Alterations of apolipoprotein ...... etroviral combination therapy.
@en
type
label
Alterations of apolipoprotein ...... etroviral combination therapy.
@ast
Alterations of apolipoprotein ...... etroviral combination therapy.
@en
prefLabel
Alterations of apolipoprotein ...... etroviral combination therapy.
@ast
Alterations of apolipoprotein ...... etroviral combination therapy.
@en
P2093
P1476
Alterations of apolipoprotein ...... etroviral combination therapy.
@en
P2093
P304
P356
10.1097/00042560-200103010-00004
P407
P577
2001-03-01T00:00:00Z